Complementary and Integrative Medicines Used by Cancer Patients to Cope With Chemotherapy-Related Taste Alterations

Introduction: Cancer is a global health problem. Taste change is one of the most common symptoms in cancer patients undergoing chemotherapy. Cancer patients often use Complementary and Integrative Medicine (CIM) to manage chemotherapy complications. Objective: This study aimed to evaluate CIM used by cancer patients to cope with chemotherapy-related taste alterations. Materials and Methods: This cross-sectional study was carried out on 318 cancer patients receiving chemotherapy in an oncology hospital in Malatya City, Turkey. The samples were recruited by convenience sampling method. The study data were collected with a data form developed by the research team. Written permissions were obtained from all participants and the Ethics Committee. Frequencies, mean scores, and standard deviation were used to present descriptive findings. The independent t-test, Chi-square test, and multivariate logistic regression analysis were used to analyze the obtained data. Results: The Mean±SD age of the patients was 65.18±8.36 years, and the mean duration of their diseases was 35.34±16.27 months. About 54.1% of the patients were female, and 42.8% had some information about CIM. Their primary source of information was other patients (49.6%), and 34.9% used CIM to cope with chemotherapy-related taste alterations. The most common method used was phytotherapy (50.5%), and the most commonly used herb was miracle fruit (21.4%). It was also determined that the frequency of CIM use was affected by age, illness duration, gender, living in a city, family history of cancer, having breast cancer, having information on CIM, having metastasis, and lacking complications (R2= 0.426, P=0.025). Conclusion: Cancer patients frequently use CIM to cope with chemotherapy-related taste alterations, and phytotherapy was the most commonly-used CIM. © 2022. All Rights Reserved.This research did not receive any grant from funding agencies in the public, commercial, or non-profit sectors

The factors affecting sleep quality in type 2 diabetes patients

2-s2.0-85075294425Objective: Research was planned with the aim of determining the sleep quality of individuals with type 2 diabetes and the factors affecting this. Design: Descriptive and cross-sectional study Setting: Endocrinology Department of the Internal Medicine Section of Ege University Medical Faculty Hospital, Manisa Celal Bayar University Hafsa Sultan Hospital, and Balıkesir University Medical Faculty Hospital Subjects: The research was conducted between May 2014 and February 2015 on 366 individuals with type 2 diabetes. Intervention: Non-interventional Main outcome measure: The sleep quality of individuals with type 2 diabetes and the factors affecting this Results: The total Pittsburgh Sleep Quality Index (PSQI) scores of individuals who had had diabetes for 1-4 years and 5-9 years were found to be significantly higher than the scores of those who had had diabetes for less than one year or more than ten years (f = 10.85, p = 0.000). The total PSQI scores of individuals using oral anti diabetic (OAD) and insulin diabetes treatment were significantly higher than the scores of patients receiving only diet treatment or OAD + insulin (f = 3.03, p = 0.029). A significant relationship was found between the HbA1c of the individuals in the study with type 2 diabetes and their total PSQI scores (p <0.01). Conclusion: It can be said that such socio-demographic characteristics as age, gender, income, duration of diabetes and diabetes treatment, and metabolic values such as the glycated haemoglobin (Hemoglobin A1c-HbA1c), fasting blood glucose and body mass index negatively affect sleep quality. © 2019, Kuwait Medical Association. All rights reserved.We wish to thank the participating type 2 diabetes mellitus patients for their participation. We also thank of the Endocrinology Department of the Internal Medicine Section of Ege University Medical Faculty Hospital, the Endocrinology Science Department of the Internal Medicine Section of Celal Bayar University Hafsa Sultan Hospital, and the Internal Medicine clinics and outpatient clinics of Bal?kesir University Medical Faculty Hospital

The factors affecting sleep quality in type 2 diabetes patients

Objective: Research was planned with the aim of determining the sleep quality of individuals with type 2 diabetes and the factors affecting this. Design: Descriptive and cross-sectional study Setting: Endocrinology Department of the Internal Medicine Section of Ege University Medical Faculty Hospital, Manisa Celal Bayar University Hafsa Sultan Hospital, and Balıkesir University Medical Faculty Hospital Subjects: The research was conducted between May 2014 and February 2015 on 366 individuals with type 2 diabetes. Intervention: Non-interventional Main outcome measure: The sleep quality of individuals with type 2 diabetes and the factors affecting this Results: The total Pittsburgh Sleep Quality Index (PSQI) scores of individuals who had had diabetes for 1-4 years and 5-9 years were found to be significantly higher than the scores of those who had had diabetes for less than one year or more than ten years (f = 10.85, p = 0.000). The total PSQI scores of individuals using oral anti diabetic (OAD) and insulin diabetes treatment were significantly higher than the scores of patients receiving only diet treatment or OAD + insulin (f = 3.03, p = 0.029). A significant relationship was found between the HbA1c of the individuals in the study with type 2 diabetes and their total PSQI scores (p <0.01). Conclusion: It can be said that such socio-demographic characteristics as age, gender, income, duration of diabetes and diabetes treatment, and metabolic values such as the glycated haemoglobin (Hemoglobin A1c-HbA1c), fasting blood glucose and body mass index negatively affect sleep quality. © 2019, Kuwait Medical Association. All rights reserved